Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -3.338M
March 31, 2026 -1.492M
December 31, 2025 -1.379M
September 30, 2025 -2.548M
June 30, 2025 -2.984M
March 31, 2025 -3.466M
December 31, 2024 -4.31M
September 30, 2024 -4.054M
June 30, 2024 -3.906M
March 31, 2024 -4.379M
December 31, 2023 -3.932M
September 30, 2023 -3.917M
June 30, 2023 -3.741M
March 31, 2023 -3.088M
Date Value
December 31, 2022 -3.088M
September 30, 2022 -3.507M
June 30, 2022 -3.248M
March 31, 2022 -3.207M
December 31, 2021 -3.022M
September 30, 2021 -2.529M
June 30, 2021 -2.357M
March 31, 2021 -1.989M
December 31, 2020 -2.037M
September 30, 2020 -1.841M
June 30, 2020 -1.635M
March 31, 2020 -1.918M
December 31, 2019 -1.814M
September 30, 2019 -1.16M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
IDEXX Laboratories, Inc. 1.233B
Neogen Corp. 31.90M
QuidelOrtho Corp. -211.20M
Aspira Women's Health, Inc. -5.113M
Biomerica, Inc. -3.422M